Profhilo Stractura Consent form
Profhilo Stractura Consent form
Profhilo Structura is an injectable hyaluronic acid treatment manufactured using patented NAHYCO® technology. It contains stabilised high- and low-molecular-weight hyaluronic acid and is designed for administration into the superficial facial fat compartments.
The treatment aims to improve age-related changes in facial soft tissue, particularly loss of midface support, facial hollowing and skin laxity.
Unlike conventional dermal fillers, which are primarily used to add volume and contour, Profhilo Structura is intended to support the quality and structure of superficial facial adipose tissue.
Potential benefits include:
- Improved appearance of midface volume loss.
- Improved soft tissue support.
- Reduced appearance of facial hollowing.
- Improvement in facial contours and skin laxity.
- Gradual improvement in overall facial appearance.
Individual results vary, and improvement cannot be guaranteed.
2. TREATMENT PROCEDURE
Profhilo Structura is administered into the appropriate superficial facial fat compartments following a clinical assessment.
Treatment typically involves an entry point created using a needle, followed by the introduction of a blunt-tipped cannula.
Patients may experience pressure, mild discomfort or a temporary aching sensation during injection.
A topical anaesthetic may be used if appropriate.
A typical initial treatment course consists of two sessions approximately four weeks apart. Further sessions and maintenance treatments may be recommended according to individual clinical response and the manufacturer’s current guidance.
3. EXPECTED RESULTS
Results develop progressively rather than immediately.
Some patients notice improvements within the first few weeks, with further changes following completion of the initial treatment course.
Results may last approximately six months, although the duration varies between individuals.
Factors including age, facial anatomy, lifestyle, underlying medical conditions and individual biological response may affect treatment outcomes.
Further treatment may be required to maintain or optimise results.
4. CONTRAINDICATIONS
Treatment should not proceed in the following circumstances:
- Pregnancy or breastfeeding.
- Known allergy or hypersensitivity to hyaluronic acid or another product component.
- Active infection or inflammation affecting the treatment area.
- Age under 18 years.
The practitioner may postpone or decline treatment if any medical condition or clinical finding makes the procedure unsuitable.
5. MEDICAL PRECAUTIONS
Please inform your practitioner if you have any of the following:
- Previous allergic reactions or anaphylaxis.
- Autoimmune or inflammatory medical conditions.
- Immunosuppression or immunosuppressive medication.
- Diabetes or impaired wound healing.
- Recurrent cold sores or herpes simplex.
- Bleeding disorders or use of anticoagulant medication.
- A history of keloid or hypertrophic scarring.
- Recent dental treatment, facial procedures or other injectable treatments.
- Previous facial fillers, implants or permanent injectable materials.
- Current or recent systemic infection.
- Any other significant medical condition or medication.
You should also disclose any forthcoming important social or professional events, as bruising or swelling may occur.
6. COMMON SIDE EFFECTS
The following reactions may occur following treatment:
- Redness at the injection sites.
- Local swelling or puffiness.
- Bruising.
- Mild pain, tenderness or discomfort.
- Temporary visible or palpable bumps.
- Itching or irritation.
- Temporary altered sensation around the treatment area.
Most minor reactions settle within several days, although bruising, swelling or tenderness may occasionally persist longer.
7. LESS COMMON AND RARE COMPLICATIONS
Infection
Any injection that breaks the skin carries a risk of infection. This may require medical assessment, antibiotics or other treatment.
Persistent lumps or nodules
Firmness, palpable material, nodules or delayed inflammatory reactions may occur. Some cases may require additional medical treatment.
Allergic or hypersensitivity reactions
Reactions may include itching, rash, swelling or urticaria. Severe allergic reactions, including anaphylaxis, are rare but potentially life-threatening.
Delayed inflammatory reactions
Swelling, tenderness or inflammation may develop weeks or months after treatment, sometimes in association with illness or immune activation.
Asymmetry or unsatisfactory results
Treatment may produce unequal improvements or an outcome that does not meet expectations. Additional treatment may be necessary.
Nerve injury
Needle or cannula placement may rarely cause nerve irritation or injury, potentially resulting in altered sensation or muscle weakness. This may be temporary or, exceptionally, permanent.
Vascular occlusion and tissue damage
Accidental injection into a blood vessel, or compression of a blood vessel by injected material, can interfere with circulation.
This may cause tissue ischaemia, skin damage or necrosis. Rare but serious complications of facial hyaluronic acid injections include visual impairment, blindness and stroke.
These complications require immediate emergency assessment and treatment. The use of a cannula does not eliminate vascular risk.
No or limited response
Some patients may experience little improvement, an unexpectedly short duration of benefit or dissatisfaction with the outcome.
8. WARNING SIGNS REQUIRING URGENT ATTENTION
Contact the clinic immediately if you develop:
- Severe or increasing pain.
- Unexpected skin blanching, darkening or mottled discolouration.
- Rapidly increasing or unusual swelling.
- Increasing redness, warmth, tenderness or suspected infection.
- Persistent or progressively worsening lumps.
Seek emergency medical attention immediately for:
- Any sudden visual disturbance or loss of vision.
- Sudden severe headache, facial weakness, difficulty speaking or other stroke-like symptoms.
- Difficulty breathing, tongue or throat swelling, or symptoms of a severe allergic reaction.
These symptoms must not be left until a routine review appointment.
9. AFTERCARE INSTRUCTIONS
Following treatment:
- Avoid touching or applying make-up to the treated areas for approximately 12 hours.
- Avoid strenuous exercise and swimming for 24 hours.
- Cleanse the skin gently for the first 48 hours.
- Avoid unnecessary pressure or massage over the treated areas.
- Avoid facial massage or additional facial aesthetic treatments for approximately two weeks unless advised otherwise.
- Avoid excessive heat exposure, including saunas, steam rooms and sunbeds, during the initial recovery period.
- Avoid excessive sun exposure while the skin is recovering.
- Consider sleeping with your head slightly elevated for the first night if swelling occurs.
Mild swelling and bruising may be expected, but persistent or worsening symptoms should be reported.
You will be provided with appropriate clinic contact details for post-treatment concerns.
10. ALTERNATIVE TREATMENTS
Alternative approaches may include:
- Conventional hyaluronic acid dermal fillers.
- Other injectable skin or tissue treatments.
- Energy-based or skin-tightening procedures where clinically appropriate.
- Surgical facial rejuvenation.
- No treatment.
The most appropriate option depends on the patient’s facial anatomy, degree of volume loss, skin laxity, medical history and treatment objectives.
11. PHOTOGRAPHIC DOCUMENTATION
Clinical photographs may be recommended before and after treatment to document the presenting condition and assess treatment response.
Photographs forming part of the confidential clinical record will be stored and processed in accordance with the clinic’s privacy policy and applicable data protection requirements.